FFilingLens
Quarterly TTM Annual
Income Balance Cash flow
8Y

Three-Statement Breakdown

AEP
2026-06-30 · figures in $M

Not enough comparable history yet for a verdict.

CASH -3.0%
197
TOTAL DEBT +8.1%
48,830
NET DEBT +8.2%
48,633
NET DEBT / ANN. EBITDA -6.7%
5.63× TARGET <2.0×
Balance sheet FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 YoY
Cash & equivalents
RESTATED · WAS 203 10-Q
234 247 393 403 509 330 203 197 -3.0%
Accounts receivable
RESTATED · WAS 2,632 10-Q
1,926 1,705 1,843 1,942 2,668 2,447 2,632 2,867 +8.9%
Inventories
NOT DISCLOSED 10-Q
— — — — — — — 1,046 —
Other current assets
RESTATED · WAS 286 10-Q
209 156 127 130 255 274 287 212 -26.1%
Total current assets
RESTATED · WAS 5,789 10-Q
4,114 4,078 4,352 7,809 6,776 6,082 5,789 6,052 +4.5%
Current ratio
10-Q
0.48× 0.40× 0.44× 0.63× 0.51× 0.53× 0.44× 0.45× +2.1%
Goodwill
RESTATED · WAS 52 10-Q
52 52 52 52 52 52 53 53 +0.0%
Property, plant & equipment
RESTATED · WAS 715 10-K
55,099 60,138 63,902 66,001 73,339 564 715 736 +2.9%
Total assets
RESTATED · WAS 93,469 10-Q
68,803 75,892 80,757 87,669 93,403 96,684 103,078 114,460 +11.0%
Return on assets (annualized)
10-Q
2.8% 2.5% 2.7% 2.8% 2.5% 2.3% 2.9% 3.2% +11.8%
Accounts payable
RESTATED · WAS 2,638 10-Q
1,874 2,086 1,710 2,055 2,671 2,032 2,638 3,429 +30.0%
Short-term debt
RESTATED · WAS 1,996 10-Q
1,698 1,599 2,086 2,154 2,486 2,490 3,335 3,194 -4.2%
Total current liabilities
RESTATED · WAS 13,009 10-Q
8,649 10,299 9,927 12,427 13,266 11,584 13,009 13,314 +2.3%
Long-term debt
RESTATED · WAS 39,308 10-Q
21,648 25,127 28,986 31,301 34,315 37,653 39,308 44,128 +12.3%
Total liabilities
10-Q
49,635 55,870 59,938 64,945 69,235 71,356 76,054 82,204 +8.1%
Net debt
10-Q
25,023 29,317 33,159 35,665 40,404 42,643 44,964 48,633 +8.2%
Temporary equity
NOT DISCLOSED
69 66 0 — — 42 38 — —
Stockholders' equity
RESTATED · WAS 26,986 10-Q
19,059 19,913 20,774 22,680 24,123 25,286 26,986 32,218 +19.4%
Net debt / TTM EBITDA
NOT DISCLOSED 10-Q
— — — — 6.16× 6.58× 6.03× 5.63× -6.7%

Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.

No comparable bridge for this view yet.

↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM SRC 10-Q FILED 2026-07-30 ↗